Curriculum Vitaes

Hamatani Toshio

  (浜谷 敏生)

Profile Information

Affiliation
Professor, Department of Clinical Regenerative Medicine, Fujita Health University

Other name(s) (e.g. nickname)
Fujita Medical Innovation Center, Reproduction Center
Researcher number
60265882
J-GLOBAL ID
200901079698132110
researchmap Member ID
1000228127

Education

 2

Committee Memberships

 13

Major Papers

 141
  • Youki Takezawa, Maki Iwai, Yukiko Fujiki, Ryo Yokomizo, Harue Kishigami, Mami Miyado, Natsuko Kawano, Mitsutoshi Yamada, Miyuki Shindo, Miki Suzuki, Ban Sato, Daiki Katano, Shintaro Kamijo, Toshio Hamatani, Mamoru Tanaka, Akihiro Umezawa, Woojin Kang, Kenji Miyado
    Laboratory Investigation, 100026-100026, Jan, 2023  Peer-reviewed
  • Shintaro Kamijo, Toshio Hamatani, Hiroyuki Sasaki, Hiroki Suzuki, Akane Abe, Osamu Inoue, Maki Iwai, Seiji Ogawa, Kei Odawara, Kanako Tanaka, Mutsumi Mikashima, Masami Suzuki, Kenji Miyado, Ryo Matoba, Yasushi Odawara, Mamoru Tanaka
    Reproductive Biology and Endocrinology, 20(1), Aug 30, 2022  
    Abstract Objective To generate an effective embryo prediction model and identify a non-invasive evaluation method by analyzing microRNAs (miRNAs) in embryo culture medium. Design Analysis of microRNA profiles from spent culture medium of blastocysts with good morphology that did or did not result in pregnancy. Setting Clinical and experimental research. Patients Sixty patients who underwent thawed embryo transfer of blastocysts after intracytoplasmic sperm injection. Intervention(s) None. Main outcome measure(s) The association of miRNA abundance levels secreted by blastocysts in culture medium and implantation success. Results Our RNA sequencing analysis found a total of 53 differentially expressed miRNAs in the culture media of pregnancy and non-pregnancy groups. Twenty-one miRNAs were analyzed for their potential to predict implantation success. Eight miRNAs (hsa-miR-191-5p, hsa-miR-320a, hsa-miR-92a-3p, hsa-miR-509-3p, hsa-miR-378a-3p, hsa-miR-28-3p, hsa-miR-512-5p, and hsa-miR-181a-5p) were further extracted from the results of a logistic regression analysis of qPCR Ct values. A prediction model for high-quality blastocysts was generated using the eight miRNAs, with an average accuracy of 0.82 by 5-fold cross validation. Conclusion We isolated blastocyst miRNAs that may predict implantation success and created a model to predict viable embryos. Increasing the number of investigated cases and further studying the effect of each miRNA on embryonic development is needed to refine the miRNA-based predictive model.
  • Ichikawa T, Ota I, Kuwabara Y, Tsushima R, Hamatani T, Hiraike O, Takeshita T, Osuga Y, Akira S
    Journal of Obstetrics and Gynaecology Research, 46(10) 1940-1950, Oct 1, 2020  
    Aim: Women undergoing infertility treatment often need to balance work and fertility treatment. Therefore, we evaluated the quality of life (QOL) and impact of infertility treatment on Japanese working women and their careers. Methods: We conducted an online questionnaire at 18 clinics in Japan. Responses were collected from 835 women, 713 of whom were working. The participants were divided into three groups based on treatment stage. Data were collected using the FertiQoL and an original questionnaire created by the authors. The Mann–Whitney U test and a multinomial logistic analysis were used. Results: Approximately 90% of the participants felt that treatment could hinder their work and 8% had quit their jobs. Low QOL was associated with sadness and despair due to infertility and mood disorders, disruptions to life and work, and the complicated medications and procedures involved in treatment. Social isolation and the effect of fertility treatment on daily life and work strongly hindered the careers of working women in the third stage of treatment (in vitro fertilization and intracytoplasmic sperm injection). Approximately 70% of the participants required support to subsidize treatment costs and sought shorter working hours and flextime systems. Only 55% informed their workplaces about the fertility treatment, but about 70% easily gained understanding by informing them. Conclusions: For many working women, infertility treatment posed barriers to their careers, which could explain the low QOL. Urgent introduction of a support system is necessary in Japan, and understanding and social acceptance of infertility appears to be important.
  • Ogawa S, Yamada M, Nakamura A, Sugawara T, Nakamura A, Miyajima S, Harada Y, Ooka R, Okawa R, Miyauchi J, Tsumura H, Yoshimura Y, Miyado K, Akutsu H, Tanaka M, Umezawa A, Hamatani T
    Stem Cell Reports, 12(6) 1366-1379, Jun 11, 2019  
    © 2019 The Authors Zygotic genome activation (ZGA) begins after fertilization and is essential for establishing pluripotency and genome stability. However, it is unclear how ZGA genes prevent mitotic errors. Here we show that knockout of the ZGA gene Zscan5b, which encodes a SCAN domain with C2H2 zinc fingers, causes a high incidence of chromosomal abnormalities in embryonic stem cells (ESCs), and leads to the development of early-stage cancers. After irradiation, Zscan5b-deficient ESCs displayed significantly increased levels of γ-H2AX despite increased expression of the DNA repair genes Rad51l3 and Bard. Re-expression of Zscan5b reduced γ-H2AX content, implying a role for Zscan5b in DNA damage repair processes. A co-immunoprecipitation analysis showed that Zscan5b bound to the linker histone H1, suggesting that Zscan5b may protect chromosomal architecture. Our report demonstrates that the ZGA gene Zscan5b is involved in genomic integrity and acts to promote DNA damage repair and regulate chromatin dynamics during mitosis. In this article, Yamada and colleagues show that Zscan5b deficiency increases DNA stress, compromises chromosomal structure during mitosis, and leads to the development of early-stage cancers. Zscan5b deficiency may offer a murine model of human chromosomal breakage syndromes.
  • Iwai M, Hamatani T, Nakamura A, Kawano N, Kanai S, Kang W, Yoshii N, Odawara Y, Yamada M, Miyamoto Y, Saito T, Saito H, Miyado M, Umezawa A, Miyado K, Tanaka M
    Laboratory Investigation, 99(2) 200-209, Feb 1, 2019  
    © 2018, United States & Canadian Academy of Pathology. Tetraspanin CD9 is essential for sperm–egg fusion and also contributes to uterine repair through microexosome formation. Microexosomes share CD9 with exosomes and are released from eggs and uterine epithelial cells. However, the mechanism for the formation of microexosomes remains unknown. To address this issue, we examined membrane localization and extracellular release of CD9 proteins using uterine epithelial cells and secretions in mice and humans. In mice, CD9 localized predominantly on the basal region of the plasma membrane and relocated to the apical region upon embryo implantation. Furthermore, extracellular CD9 proteins were detected in uterine secretions of mice and women undergoing infertility treatment, but were below detectable levels in supernatants of pluripotent stem cells. Ultrastructural analysis demonstrated that membrane projections were shortened and the number of mitochondria was reduced in uterine epithelial cells lacking Cd9 genes. Our results suggest that CD9 repositioning and release affect both membrane structures and mitochondrial state in the uterus, and contribute to female fertility.
  • Hiroyuki Sasaki, Toshio Hamatani, Shintaro Kamijo, Maki Iwai, Masato Kobanawa, Seiji Ogawa, Kenji Miyado, Mamoru Tanaka
    Frontiers in endocrinology, 10 811-811, 2019  Corresponding author
    Reproductive capacity in women starts to decline beyond their mid-30s and pregnancies in older women result in higher rates of miscarriage with aneuploidy. Age-related decline in fertility is strongly attributed to ovarian aging, diminished ovarian reserves, and decreased developmental competence of oocytes. In this review, we discuss the underlying mechanisms of age-related decline in oocyte quality, focusing on oxidative stress (OS) in oocytes. The primary cause is the accumulation of spontaneous damage to the mitochondria arising from increased reactive oxygen species (ROS) in oocytes, generated by the mitochondria themselves during daily biological metabolism. Mitochondrial dysfunction reduces ATP synthesis and influences the meiotic spindle assembly responsible for chromosomal segregation. Moreover, reproductively aged oocytes produce a decline in the fidelity of the protective mechanisms against ROS, namely the ROS-scavenging metabolism, repair of ROS-damaged DNA, and the proteasome and autophagy system for ROS-damaged proteins. Accordingly, increased ROS and increased vulnerability of oocytes to ROS lead to spindle instability, chromosomal abnormalities, telomere shortening, and reduced developmental competence of aged oocytes.
  • Kasuga, Y, Nishio, H, Miyakoshi, K, Sato, S, Sugiyama, J, Matsumoto, T, Tanaka, K, Ochiai, D, Minegishi, K, Hamatani, T, Iwata, T, Morisada, T, Nakamura, M, Fujii, T, Kuji, N, Aoki, D, Tanaka, M
    Int J Gynecol Cancer, 26(1) 163-168, Jan, 2016  
    To investigate pregnancy outcomes in women after abdominal radical trachelectomy (RT) for early-stage cervical cancer.|The patients' background, fertility, and pregnancy outcomes were reviewed in a total of 61 pregnancies in 48 of 172 women who underwent abdominal RT at Keio University Hospital between September 2002 and December 2013.|There were 5 women with stage IA1, 2 with stage IA2, and 41 with stage IB1. Histological types were as follows: squamous cell carcinoma (n = 36), adenocarcinoma (n = 10), and adenosquamous cell carcinoma (n = 2). The pregnancy rate of women attempting to conceive after abdominal RT was 44% (48/109). The mean ± SD duration from abdominal RT to conception was 3.1 ± 1.9 years. Of 61 pregnancies, 42 pregnancies were achieved by fertility treatment (in vitro fertilization-embryo transfer, 39; intrauterine insemination, 3). After excluding one pregnancy without detailed clinical information, there were 42 live births (5 in 22-27 weeks, 11 in 28-33weeks, 20 in 34-36 weeks, and 6 in 37-38 weeks), 13 miscarriages, and 5 ongoing pregnancies. While there were 10 first trimester miscarriages, 3 pregnancies ended in the second trimester owing to chorioamnioniti
  • Osamu Inoue, Toshio Hamatani, Nobuyuki Susumu, Wataru Yamagami, Seiji Ogawa, Takashi Takemoto, Akira Hirasawa, Kouji Banno, Naoaki Kuji, Mamoru Tanaka, Daisuke Aoki
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 14 2, Jan, 2016  Peer-reviewed
  • Tsumura H, Ito M, Takami M, Arai M, Li XK, Hamatani T, Igarashi A, Takada S, Miyado K, Umezawa A, Ito Y
    Biochem Biophys Rep., 5 203-210, 2015  Peer-reviewed
  • Mayumi Shoji, Toshio Hamatani, Shoko Ishikawa, Naoaki Kuji, Hiroaki Ohta, Hideo Matsui, Yasunori Yoshimura
    SCIENTIFIC REPORTS, 4 5203, Jun, 2014  Peer-reviewed
  • Kana Sugawara, Toshio Hamatani, Mitsutoshi Yamada, Seiji Ogawa, Shintaro Kamijo, Naoaki Kuji, Hidenori Akutsu, Kenji Miyado, Yasunori Yoshimura, Akihiro Umezawa
    SCIENTIFIC REPORTS, 4 4599, Apr, 2014  Peer-reviewed
  • Natsuko Kawano, Kenji Miyado, Noriko Yoshii, Seiya Kanai, Hidekazu Saito, Mami Miyado, Noboru Inagaki, Yasushi Odawara, Toshio Hamatani, Akihiro Umezawa
    SCIENTIFIC REPORTS, 4, Apr, 2014  Peer-reviewed
  • Tomoko Yamada-Fukunaga, Mitsutoshi Yamada, Toshio Hamatani, Nana Chikazawa, Seiji Ogawa, Hidenori Akutsu, Takumi Miura, Kenji Miyado, Juan J. Tarín, Naoaki Kuji, Akihiro Umezawa, Yasunori Yoshimura
    Reproductive Biology and Endocrinology, 11(1) 108, Nov 21, 2013  Peer-reviewed
  • Hiroshi Nishio, Takuma Fujii, Juri Sugiyama, Naoaki Kuji, Mamoru Tanaka, Toshio Hamatani, Kei Miyakoshi, Kazuhiro Minegishi, Hiroshi Tsuda, Takashi Iwata, Kyoko Tanaka, Takeshi Fukuchi, Yuji Takehara, Yasunori Yoshimura, Daisuke Aoki
    HUMAN REPRODUCTION, 28(7) 1793-1798, Jul, 2013  Peer-reviewed
  • Yoshii N, HHamatani T, Inagaki N, Hosaka T, Machiya R, Inoue O, Yoshimura Y, Odawara Y
    Reprod Biol Endocrinol, 11 37-37, 2013  Peer-reviewed
  • Mitsutoshi Yamada, Kazumi Takanashi, Toshio Hamatani, Akiyoshi Hirayama, Hidenori Akutsu, Tomoko Fukunaga, Seiji Ogawa, Kana Sugawara, Kosaku Shinoda, Tomoyoshi Soga, Akihiro Umezawa, Naoaki Kuji, Yasunori Yoshimura, Masaru Tomita
    SCIENTIFIC REPORTS, 2 930-930, Dec, 2012  Peer-reviewed
  • Toshio Hamatani
    FERTILITY AND STERILITY, 97(2) 275-281, Feb, 2012  Peer-reviewed
  • Juan J. Tarin, Toshio Hamatani, Antonio Cano
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 8(8) 53-53, May, 2010  Peer-reviewed
  • Mitsutoshi Yamada, Toshio Hamatani, Hidenori Akutsu, Nana Chikazawa, Naoaki Kuji, Yasunori Yoshimura, Akihiro Umezawa
    Human Molecular Genetics, 19(3) 480-493, Nov 14, 2009  
  • T Hamatani, T Daikoku, HB Wang, H Matsumoto, MG Carter, MSH Ko, SK Dey
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 101(28) 10326-10331, Jul, 2004  Peer-reviewed
  • Hamatani T, Carter MG, Sharov AA, Ko MS
    Dev Cell. 2004 Jan;6(1):117-31. Epub 2003 Dec 18., 6(1) 117-131-131, Dec 8, 2003  Peer-reviewed
  • T Hamatani, K Tanabe, K Kamei, N Sakai, Y Yamamoto, Y Yoshimura
    BIOLOGY OF REPRODUCTION, 62(5) 1201-1208, May, 2000  Peer-reviewed

Misc.

 99

Presentations

 147

Teaching Experience

 6

Research Projects

 28